You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Healthy Stem Cell Donor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Improved Methods of Cell Selection for Bone Marrow Transplant

Recruiting
  • Graft-Versus-Host Disease
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 23, 2023

Non-interventional, Long-term Safety Data Collection of Zarzio®

Active, not recruiting
  • Hematopoietic Stem Cell Mobilization
    • Frankfurt/Main, Hessen, Germany
    • +1 more
    Jan 24, 2022

    Solid Tumors Trial in Boynton Beach (White Blood Cells/Granulocytes)

    Enrolling by invitation
    • Solid Tumors
    • White Blood Cells/Granulocytes
    • Boynton Beach, Florida
      South Florida Bone Marrow / Stem Cell Transplant Institute
    May 5, 2022

    Hematopoietic Organs; Disorder Trial in Hong Kong (CD62L depleted donor lymphocyte infusion)

    Recruiting
    • Hematopoietic Organs; Disorder
    • CD62L depleted donor lymphocyte infusion
    • Hong Kong, Hong Kong
      Hong Kong Children's Hospital
    Sep 6, 2023

    Nursing Students Trial (Peer education)

    Not yet recruiting
    • Nursing Students
    • Peer education
    • (no location specified)
    Feb 10, 2023

    Hematopoietic Stem Cell Transplantation, Hematologic Malignancy Trial (CliniMACS®)

    Not yet recruiting
    • Hematopoietic Stem Cell Transplantation
    • Hematologic Malignancy
    • CliniMACS®
    • (no location specified)
    Oct 17, 2023

    Related Donors Donating PBSC to a Family Member, Healthy Donors, Acute Myelogenous Leukemia Trial in United States (MGTA-145,

    Terminated
    • Related Donors Donating PBSC to a Family Member
    • +4 more
    • MGTA-145
    • Plerixafor
    • Duarte, California
    • +7 more
    Apr 13, 2022

    AML/MDS Trial in Copenhagen (iDLI)

    Recruiting
    • AML/MDS
    • iDLI
    • Copenhagen, Denmark
      Copenhagen University Hospital, Rigshospitalet
    Jan 13, 2023

    Predict T Cell Chimerism After MSD SCT for SCD?

    Recruiting
    • Sickle Cell Disease
    • Alemtuzumab Injection [Campath]
    • Amsterdam, Netherlands
      Amsterdam Medical Centre
    Jun 20, 2023

    Leukemia Trial (Donor Enriched Activated Natural Killer Cell Infusion)

    Withdrawn
    • Leukemia
    • Donor Enriched Activated Natural Killer Cell Infusion
    • (no location specified)
    Dec 20, 2022

    DOCK8 Deficiency Trial run by the National Cancer Institute (NCI) (Reduced-intensity hematopoietic stem cell,

    Recruiting
    • DOCK8 Deficiency
    • Reduced-intensity hematopoietic stem cell
    • +6 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 27, 2023

    Stem Cell Transplant Complications, Graft Vs Host Disease, Myeloid Leukemia, Acute Trial in Boston (radiation, drug, biological,

    Recruiting
    • Stem Cell Transplant Complications
    • +4 more
    • Radiation
    • +7 more
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Jan 19, 2023

    Donor COVID-19 Infection Status on the Recipient in Allo-HSCT

    Recruiting
    • COVID-19
    • Hematopoietic Stem Cell Transplantation
      • Suzhou, Jiangsu, China
        First Affiliated Hospital of Soochow University
      Jan 10, 2023

      Renal Failure Trial in Chicago (Biological/Vaccine: Enriched Hematopoetic Stem Cell Infusion)

      No longer available
      • Renal Failure
      • Biological/Vaccine: Enriched Hematopoetic Stem Cell Infusion
      • Chicago, Illinois
        Northwestern Memorial Hospital
      Jul 15, 2022

      Haematological Malignancies Trial in London, Manchester (CD25/71 allodepleted donor T-cells)

      Completed
      • Haematological Malignancies
      • CD25/71 allodepleted donor T-cells
      • London, United Kingdom
      • +1 more
      Jul 18, 2022

      Acute Myeloid Leukemia, Allogeneic Stem Cell Transplantation Trial (Siremadlin)

      Recruiting
      • Acute Myeloid Leukemia
      • Allogeneic Stem Cell Transplantation
      • Tel Aviv, Israel
      • +2 more
      Jan 23, 2023

      Severe Aplastic Anemia, MDS (Myelodysplastic Syndrome) Trial in Baltimore, Bethesda, Minneapolis (Miltenyi CD34 Reagent System,

      Recruiting
      • Severe Aplastic Anemia
      • MDS (Myelodysplastic Syndrome)
      • Miltenyi CD34 Reagent System
      • Donor derived G-CSF mobilized PBC
      • Baltimore, Maryland
      • +2 more
      Jan 25, 2023

      Multiple Myeloma, CLL, Chronic Lymphocytic Leukemia Trial in Los Angeles (radiation, procedure, biological, drug)

      Active, not recruiting
      • Multiple Myeloma
      • +4 more
      • Total Body Irradiation
      • +5 more
      • Los Angeles, California
        Cedars Sinai Medical Center
      Dec 21, 2022

      Multiple Myeloma Trial in New York (drug, biological, procedure)

      Active, not recruiting
      • Multiple Myeloma
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      Jan 3, 2023

      Allogeneic Stem Cell Transplant, Viral Infection, Viral Reactivation Trial in Cincinnati (Viral specific VST Infusion)

      Recruiting
      • Allogeneic Stem Cell Transplant
      • +2 more
      • Viral specific VST Infusion
      • Cincinnati, Ohio
        Cincinnati Children's Hospital Medical Center
      Aug 15, 2022

      Leukemia, Stem Cell Transplantation Trial in Munich (FBTA05)

      Withdrawn
      • Leukemia
      • Stem Cell Transplantation
      • Munich, Bavaria, Germany
        3. Medizinische Klinik, Klinikum rechts der Isar der TU München
      Dec 5, 2022

      Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Houston (procedure, drug, other)

      Active, not recruiting
      • Acute Myeloid Leukemia
      • Myelodysplastic Syndrome
      • Allogeneic Hematopoietic Stem Cell Transplantation
      • +7 more
      • Houston, Texas
        M D Anderson Cancer Center
      Oct 6, 2022

      Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (radiation, procedure, drug)

      Recruiting
      • Hematopoietic and Lymphoid Cell Neoplasm
      • Total-Body Irradiation
      • +5 more
      • Philadelphia, Pennsylvania
        Sidney Kimmel Cancer Center at Thomas Jefferson University
      Sep 7, 2022

      Hematologic Malignancy Trial in Tuebingen,, Tuebingen (CD45RA depleted donor lymphocyte infusion (DLI))

      Recruiting
      • Hematologic Malignancy
      • CD45RA depleted donor lymphocyte infusion (DLI)
      • Tuebingen,, Germany
      • +1 more
      Jul 13, 2023

      Multiple Myeloma, Refractory Multiple Myeloma Trial (procedure, drug, radiation)

      Withdrawn
      • Multiple Myeloma
      • Refractory Multiple Myeloma
      • nonmyeloablative allogeneic hematopoietic stem cell transplantation
      • +7 more
      • (no location specified)
      Jan 4, 2023